Evidence map›Paper›PMID 40484810›Full record

ArticleJournal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG2025

International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives.

Manuel P Pereira, Katarina Stevanovic, Emek Kocatürk, Cathrin Meesch, Ingrid van Hofman, Prema S Vaswani, Jonathan A Bernstein, Dayanne Bruscky, Herberto J Chong-Neto, Chia-Yu Chu and 25 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. International survey of treatment practices for atopic dermatitis in pregnant and breastfeeding women: Physician perspectives.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Manuel P PereiraInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Katarina StevanovicInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Emek KocatürkInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Cathrin MeeschInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ingrid van HofmanGA2LEN, Global Allergy and Asthma Excellence Network, Berlin, Germany.
Prema S VaswaniInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Jonathan A BernsteinUniversity of Cincinnati College of Medicine, Division of Rheumatology, Allergy and Immunology, Partner of Bernstein Allergy Group and Bernstein Clinical Research Center.
Dayanne BrusckyAllergy and Immunology Research Center, Federal University of Pernambuco, Recife, Brazil.
Herberto J Chong-NetoDivision of Allergy and Immunology-Complexo Hospital de Clínicas-Federal University of Paraná, Brazil.
Chia-Yu ChuDepartment of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
Roberta Fachini Jardim CriadoDepartment of Dermatology, Centro Universitário FMABC, Alergoskin Alergia e Dermatologia - UCARE/ADCARE Center of Excellence - GA2LEN, Santo André, Brazil.
Luis Felipe EnsinaCPAlpha Clinical Research and Allergy Center, Barueri, Brazil.
Ana M Giménez-ArnauDepartment of Dermatology, Hospital del Mar Research Institute, Universitat Pompeu Fabra, Barcelona, Spain.
Kiran GodseD Y Patil University school of medicine, Navi Mumbai, India.
Maia GotuaCenter of Allergy and Immunology, ADCARE Center, Tbilisi, Georgia.
Stamatios Gregoriou1st Department of Dermatology and Venereology, Andreas Sygros Hospital, Faculty of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Kanokvalai KulthananDepartment of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University, Siriraj ADCARE Center, Bangkok, Thailand.
Charlotte G MortzDepartment of Dermatology and Allergy Center, Odense University Hospital, Odense, Denmark.
Natasa Teovska MitrevskaDepartment of Dermatology, Remedika General Hospital, Skopje, North Macedonia.
Esen ÖzkayaDepartment of Dermatology and Venereology, İstanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
Prajwal PudasainiCivil Service Hospital, ADCARE Center, Government of Nepal, Kathmandu, Nepal.
Mara Morelo Rocha FelixAlergolife ADCARE Center, Rio de Janeiro, Brazil.
Catalina Rincón PérezGA2LEN Atopic Dermatitis Center of Reference and Excellence, Medical Specialty Unit, Secretaría de la Defensa Nacional, Mexico City, Mexico.
Claudio Alberto Salvador ParisiPediatric and Adult Allergy Sections, Italian Hospital of Buenos Aires, Buenos Aires, Argentina.
Gonzalo N RamónInstituto de Alergia e Inmunología del Sur, Bahía Blanca, Argentina.
Efstratios Vakirlis1st Department of Dermatology and Venereology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Zuotao ZhaoDepartment of Dermatology and Venereology, Peking University First Hospital, Beijing Key Laboratory of Molecular Diagnosis on Dermatoses, National Clinical Research Center for Skin and Immune Diseases, NMPA Key Laboratory for Quality Control and Evaluation of Cosmetics, Beijing, China.
Lisa A BeckUniversity of Rochester Medical Center, Rochester, New York, USA.
Marjolein de Bruin-WellerDepartment of Dermatology and Allergology, National Expertise Center for Atopic Dermatitis, University Medical Center Utrecht, Utrecht, The Netherlands.
Michael CorkSheffield Dermatology Research, IICD, University of Sheffield, Sheffield, UK.
Norito KatohNorth Campus, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Thomas WerfelDepartment of Dermatology and Allergy, Hannover Medical School, Hannover, Germany.
Margitta WormDivision of Allergy and Immunology, Department of Dermatology and Allergology, Charité - Universitätsmedizin Berlin, Berlin, Germany.ORCID 0000-0002-3449-1245
Andreas WollenbergDepartment of Dermatology and Allergy, Augsburg University Hospital, Augsburg, Germany.
Torsten ZuberbierInstitute of Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesSystemic treatment of pregnant/breastfeeding atopic dermatitis (AD) patients is challenging due to limited safety data. We explored treatment practices with systemic agents, including the guideline-recommended cyclosporine as the first systemic choice as well as emerging therapies, in this vulnerable population. PATIENTS AND

methodsThe Global Allergy and Asthma Excellence Network (GA

results103 physicians from 32 countries completed the survey, primarily dermatologists (n = 48) or allergologists (n = 43). Antihistamines were the systemic drug most often considered to be used during pregnancy/breastfeeding (n = 73/81, 90.1%), with fewer physicians considering the use of systemic agents for the first trimester compared to later stages of pregnancy. For acute flares, systemic corticosteroids (n = 34/80, 42.5%) were preferred, followed by biologics and antihistamines (each n = 15/80, 18.8%). Although the guideline-recommended cyclosporine is sometimes considered for AD during pregnancy (n = 38/81, 46.9%), it was rarely considered as the preferred drug by physicians (n = 1/80, 1.25%).

conclusionsOur study shows a misalignment between guideline recommendations and prescription patterns and highlights an unmet need for knowing and using the existing recommendations.

Indexed as

Breast FeedingDermatitis, AtopicDermatologic AgentsPractice Patterns, Physicians'Pregnancy ComplicationsAdrenal Cortex HormonesAdultBiological ProductsCyclosporineDermatologistsFemaleHistamine AntagonistsHumansPregnancySurveys and QuestionnairesAdrenal Cortex HormonesBiological ProductsCyclosporineDermatologic AgentsHistamine AntagonistsAtopic dermatitisbreastfeedingpregnancysurveysystemic treatment

Identifiers

PMID40484810
PMCPMC12435135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.